Invitae Corporation
NYSE: NVTA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Kenneth D. Knight
- Employees
- 1,700
- Headquarters
- San Francisco, United States
- IPO year
- 2015
- Market cap
- $5.4M
- Website
- https://www.invitae.com
Loading NVTA…
Loading profile data…Frequently asked questions about NVTA
What does Invitae Corporation (NVTA) do?
Invitae Corporation operates as a medical genetics enterprise, striving to integrate genetic insights into mainstream medical practice to enhance healthcare outcomes for individuals in the United States, Canada, and internationally. The company provides a comprehensive suite of offerings, including genetic testing for various clinical specializa...
Where does NVTA trade?
Invitae Corporation (NVTA) trades on the New York Stock Exchange.
What sector is NVTA in?
Invitae Corporation (NVTA) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Invitae Corporation?
Kenneth D. Knight is the chief executive officer of Invitae Corporation (NVTA).
Where is Invitae Corporation headquartered?
Invitae Corporation is headquartered in United States.
Does NVTA pay a dividend?
Invitae Corporation (NVTA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NVTA go public?
Invitae Corporation (NVTA) completed its initial public offering in 2015.